SCHEMBL24747779

SCHEMBL24747779

CC1(C)OCC(c2ncc(NC=O)cn2)O1

nearest known ligand 0.32

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CA2 P00918 1/20 0.31
HCRTR1 O43613 1/20 0.30
HCRTR2 O43614 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
TP53 P04637 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
PKM P14618 1/20 0.30
HPGD P15428 1/20 0.30
ALOX15 P16050 1/20 0.30
MAPK1 P28482 1/20 0.30
CASP1 P29466 1/20 0.30
BLM P54132 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25316992 0.76 ALDH1A1 (0.32) ALDH1A1NPSR1CA2KDM4EMEN1
SCHEMBL30853184 0.74 CA2 (0.33) ALDH1A1NPSR1CA2KDM4EMEN1
SCHEMBL24748775 0.74 CA2 (0.33) ALDH1A1NPSR1CA2KDM4EMEN1
SCHEMBL25316126 0.74 HCRTR1 (0.31) ALDH1A1NPSR1HCRTR1HCRTR2KDM4E
SCHEMBL30853192 0.74 CA2 (0.33) ALDH1A1NPSR1CA2KDM4EMEN1
SCHEMBL24748724 0.69 HCRTR1 (0.33) HCRTR1HCRTR2MEN1MAPTHPGD
SCHEMBL29183067 0.69 CA2 (0.33) ALDH1A1NPSR1CA2HCRTR2MEN1
SCHEMBL28252204 0.69 HDAC4 (0.36) ALDH1A1
SCHEMBL28668136 0.68
SCHEMBL30931250 0.68 POLB (0.47) ALDH1A1TP53MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022256679-A1 N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDE ANALOGS AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-12-08 WO disclosed